Ionis reports fourth quarter and full year 2023 financial results
WAINUA™ approved with launch underway; on track for EU and Canada approval decisions this year Positive Phase 3 olezarsen and donidalorsen data, preparing regulatory submissions for FCS and HAE,...
Elizabethl Hougen Company Phase Ionis Pharmaceuticals Foundation For Angelman Syndrome Therapeutics Summit Akcea Therapeutics Inc Ionis Pharmaceuticals Inc
Source: marketscreener.com